These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 14566406)
1. [Increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice]. Jiang H; Qian ZM; Xie JX Sheng Li Xue Bao; 2003 Oct; 55(5):571-6. PubMed ID: 14566406 [TBL] [Abstract][Full Text] [Related]
2. Iron transport in Parkinson's disease. Hirsch EC Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent. Jiang H; Song N; Xu H; Zhang S; Wang J; Xie J Cell Res; 2010 Mar; 20(3):345-56. PubMed ID: 20125122 [TBL] [Abstract][Full Text] [Related]
4. Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain. Moos T; Trinder D; Morgan EH Cell Mol Biol (Noisy-le-grand); 2000 May; 46(3):549-61. PubMed ID: 10872742 [TBL] [Abstract][Full Text] [Related]
5. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Jourdain S; Morissette M; Morin N; Di Paolo T J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487 [TBL] [Abstract][Full Text] [Related]
6. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135 [TBL] [Abstract][Full Text] [Related]
7. Age-dependent and iron-independent expression of two mRNA isoforms of divalent metal transporter 1 in rat brain. Ke Y; Chang YZ; Duan XL; Du JR; Zhu L; Wang K; Yang XD; Ho KP; Qian ZM Neurobiol Aging; 2005 May; 26(5):739-48. PubMed ID: 15708449 [TBL] [Abstract][Full Text] [Related]
8. Expression and localization of different forms of DMT1 in normal and tumor astroglial cells. Lis A; Barone TA; Paradkar PN; Plunkett RJ; Roth JA Brain Res Mol Brain Res; 2004 Mar; 122(1):62-70. PubMed ID: 14992816 [TBL] [Abstract][Full Text] [Related]
9. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration. Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381 [TBL] [Abstract][Full Text] [Related]
10. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats. Wang J; Jiang H; Xie JX Eur J Neurosci; 2007 May; 25(9):2766-72. PubMed ID: 17561842 [TBL] [Abstract][Full Text] [Related]
11. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. Aoki E; Yano R; Yokoyama H; Kato H; Araki T Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004 [TBL] [Abstract][Full Text] [Related]
12. Ontogenic changes in lactoferrin receptor and DMT1 in mouse small intestine: implications for iron absorption during early life. Lopez V; Suzuki YA; Lönnerdal B Biochem Cell Biol; 2006 Jun; 84(3):337-44. PubMed ID: 16936804 [TBL] [Abstract][Full Text] [Related]
13. Distribution of divalent metal transporter-1 in the monkey basal ganglia. Huang E; Ong WY; Connor JR Neuroscience; 2004; 128(3):487-96. PubMed ID: 15381278 [TBL] [Abstract][Full Text] [Related]
14. Potential neuroprotective effect of low dose whole-body gamma-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice. Liang Y; Li S; Zou Q; Su B Neurosci Lett; 2006 Jun; 400(3):213-7. PubMed ID: 16540245 [TBL] [Abstract][Full Text] [Related]
15. MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non-treated cagemates through close contact. Lau YS; Novikova L; Roels C Neurosci Res; 2005 Aug; 52(4):371-8. PubMed ID: 15936837 [TBL] [Abstract][Full Text] [Related]
16. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease. Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351 [TBL] [Abstract][Full Text] [Related]
17. Toki-to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice. Sakai R; Irie Y; Murata T; Ishige A; Anjiki N; Watanabe K Phytother Res; 2007 Sep; 21(9):868-73. PubMed ID: 17486689 [TBL] [Abstract][Full Text] [Related]
18. Distinct targeting and recycling properties of two isoforms of the iron transporter DMT1 (NRAMP2, Slc11A2). Lam-Yuk-Tseung S; Gros P Biochemistry; 2006 Feb; 45(7):2294-301. PubMed ID: 16475818 [TBL] [Abstract][Full Text] [Related]
19. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Hubert N; Hentze MW Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12345-50. PubMed ID: 12209011 [TBL] [Abstract][Full Text] [Related]
20. [Relationship between dopamine and iron contents in the brain of parkinsonian rats]. Jiang H; Chen WF; Xie JX Sheng Li Xue Bao; 2001 Oct; 53(5):334-8. PubMed ID: 11833414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]